KR101000608B1 - 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 - Google Patents
검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 Download PDFInfo
- Publication number
- KR101000608B1 KR101000608B1 KR1020070118030A KR20070118030A KR101000608B1 KR 101000608 B1 KR101000608 B1 KR 101000608B1 KR 1020070118030 A KR1020070118030 A KR 1020070118030A KR 20070118030 A KR20070118030 A KR 20070118030A KR 101000608 B1 KR101000608 B1 KR 101000608B1
- Authority
- KR
- South Korea
- Prior art keywords
- blotch
- polynucleotide
- mushrooms
- skin
- gene
- Prior art date
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
- C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Gene Symbol | Gene Title | mRNA Accession No |
WNT3 | wingless-type MMTV integration site family, member 3 | NM_030753 |
TFIP11 | tuftelin interacting protein 11 | NM_001008697;NM_012143 |
DUS3L | dihydrouridine synthase 3-like (S. cerevisiae) | NM_020175 |
CDH3 | cadherin 3, type 1, P-cadherin (placental) | NM_001793 |
PLAU | plasminogen activator, urokinase | NM_002658 |
AQP3 | aquaporin 3 (Gill blood group) | NM_004925 |
CENPO | centromere protein O | NM_024322 |
CDCP1 | CUB domain containing protein 1 | NM_022842;NM_178181 |
NEFL | neurofilament, light polypeptide 68kDa | NM_006158 |
TAX1BP3 | Tax1 (human T-cell leukemia virus type I) binding protein 3 | NM_014604 |
COPZ2 | coatomer protein complex, subunit zeta 2 | NM_016429 |
SSBP3 | single stranded DNA binding protein 3 | NM_001009955;NM_018070;NM_145716 |
TNFRSF21 | tumor necrosis factor receptor superfamily, member 21 | NM_014452 |
ZFP14 | zinc finger protein 14 homolog (mouse) | NM_020917 |
LOXL2 | lysyl oxidase-like 2 | NM_002318 |
CCL2 | chemokine (C-C motif) ligand 2 | NM_002982 |
RNASET2 | ribonuclease T2 | NM_003730 |
KRTCAP3 | keratinocyte associated protein 3 | NM_173853 |
SLC38A5 | solute carrier family 38, member 5 | NM_033518 |
ZNRF1 | zinc and ring finger 1 | NM_032268 |
TNC | tenascin C (hexabrachion) | NM_002160 |
SYT12 | synaptotagmin XII | NM_177963 |
STXBP5L | syntaxin binding protein 5-like | XM_045911;XM_938898 |
RBM14 | RNA binding motif protein 14 | NM_006328 |
GSR | glutathione reductase | NM_000637 |
ZC3HAV1 | zinc finger CCCH-type, antiviral 1 | NM_020119;NM_024625 |
AQP3 | aquaporin 3 (Gill blood group) | NM_004925 |
MGC17330 | HGFL gene | NM_052880 |
PRSS16 | protease, serine, 16 (thymus) | NM_005865 |
MYO1F | myosin IF | NM_012335 |
SLC12A4 | solute carrier family 12 (potassium/chloride transporters), member 4 | NM_005072 |
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | NM_002203 |
WNT5B | wingless-type MMTV integration site family, member 5B | NM_030775;NM_032642 |
HNRPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | NM_004501;NM_031844 |
LTB4R2 | leukotriene B4 receptor 2 | NM_019839 |
KCNC4 | potassium voltage-gated channel, Shaw-related subfamily, member 4 | NM_001039574;NM_004978;NM_153763 |
H2AFY2 | H2A histone family, member Y2 | NM_018649 |
BTN2A2 | butyrophilin, subfamily 2, member A2 | NM_006995;NM_181531 |
DYNLL2 | dynein, light chain, LC8-type 2 | NM_080677 |
ETV5 | ets variant gene 5 (ets-related molecule) | NM_004454 |
PCDHB13 | protocadherin beta 13 | NM_018933 |
ITGB4 | integrin, beta 4 | NM_000213;NM_001005619;NM_001005731 |
GGA2 | golgi associated, gamma adaptin ear containing, ARF binding protein 2 | NM_015044 |
JAG2 | jagged 2 | NM_002226;NM_145159 |
COL17A1 | collagen, type XVII, alpha 1 | NM_000494;NM_130778 |
DLX2 | distal-less homeobox 2 | NM_004405 |
LDLR | low density lipoprotein receptor (familial hypercholesterolemia) | NM_000527 |
GPRC5C | G protein-coupled receptor, family C, group 5, member C | NM_018653;NM_022036 |
FBXO4 | F-box protein 4 | NM_012176;NM_033484 |
STC1 | stanniocalcin 1 | NM_003155 |
COL4A2 | collagen, type IV, alpha 2 | NM_001846 |
ADAMTSL3 | ADAMTS-like 3 | NM_207517 |
KLC4 | kinesin light chain 4 | NM_138343;NM_201521;NM_201522;NM_201523 |
ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | NM_002165;NM_181353 |
GALNT14 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) | NM_024572 |
PAX6 | paired box gene 6 (aniridia, keratitis) | NM_000280;NM_001604 |
IGFL1 | IGF family-like member 1 | BG775668 |
PLAT | plasminogen activator, tissue | BX641021 |
TNS4 | tensin 4 | AF370421 |
CLSTN1 | calsyntenin 1 | AB020718 |
HOXA7 | homeobox A7 | NM_006896 |
SILV | silver homolog (mouse) | AK092881 |
MX1 | myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) /// myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) | AK096355 |
CIDEB | cell death-inducing DFFA-like effector b | AK122828 |
Gene Symbol | Gene Title | mRNA Accession No |
CEP70 | centrosomal protein 70kDa | NM_024491 |
FIGN | fidgetin | NM_018086 |
PPIG | peptidylprolyl isomerase G (cyclophilin G) | NM_004792 |
VGLL3 | vestigial like 3 (Drosophila) | NM_016206 |
CDH19 | cadherin 19, type 2 | NM_021153 |
CNTN3 | contactin 3 (plasmacytoma associated) | NM_020872 |
INVS | inversin | NM_014425;NM_183245 |
RSN | restin (Reed-Steinberg cell-expressed intermediate filament-associated protein) | NM_002956;NM_198240 |
DACT1 | dapper, antagonist of beta-catenin, homolog 1 (Xenopus laevis) | NM_016651 |
PLCB4 | phospholipase C, beta 4 | NM_000933;NM_182797 |
ERO1L | ERO1-like (S. cerevisiae) | NM_014584 |
MGC34646 | hypothetical protein MGC34646 | NM_173519 |
ZC3H7B | zinc finger CCCH-type containing 7B | NM_017590 |
CNIH4 | cornichon homolog 4 (Drosophila) | NM_014184 |
AKR1C3 | aldo-keto reductase family 1, member C3 (3-alpha hydroxysteroid dehydrogenase, type II) | NM_003739 |
GLDN | gliomedin | NM_181789 |
SCARA5 | scavenger receptor class A, member 5 (putative) | NM_173833 |
C17orf57 | chromosome 17 open reading frame 57 | NM_152347 |
ERO1LB | ERO1-like beta (S. cerevisiae) | NM_019891 |
SNX25 | sorting nexin 25 | NM_031953 |
CBWD2;CBWD3;CBWD1 | COBW domain containing 2;COBW domain containing 3;COBW domain containing 1 | NM_172003;NM_201453;NM_018491 |
PNLIPRP3 | pancreatic lipase-related protein 3 | NM_001011709 |
LRRC17 | leucine rich repeat containing 17 | NM_001031692;NM_005824 |
RUNX1T1 | runt-related transcription factor 1;translocated to, 1 (cyclin D-related) | NM_004349;NM_175634;NM_175635;NM_175636 |
C20orf19 | chromosome 20 open reading frame 19 | NM_018474 |
PDZRN3 | PDZ domain containing RING finger 3 | NM_015009 |
TMEM47 | transmembrane protein 47 | NM_031442 |
ARID4B | AT rich interactive domain 4B (RBP1- like) | NM_016374;NM_031371 |
RBMS3 | RNA binding motif, single stranded interacting protein | NM_001003792;NM_001003793;NM_014483 |
ECM2 | extracellular matrix protein 2, female organ and adipocyte specific | NM_001393 |
RGS13 | regulator of G-protein signalling 13 | NM_002927;NM_144766 |
FIGN | fidgetin | NM_018086 |
LZIC | leucine zipper and CTNNBIP1 domain containing | NM_032368 |
UQCRB | ubiquinol-cytochrome c reductase binding protein | NM_006294 |
IL17D | interleukin 17D | NM_138284 |
ASPH | aspartate beta-hydroxylase | NM_004318;NM_020164;NM_032466;NM_032467;NM_032468 |
AKAP9 | A kinase (PRKA) anchor protein (yotiao) 9 | NM_005751;NM_147166;NM_147171;NM_147185 |
ZNF594 | zinc finger protein 594 | XM_290737;XM_932723;XM_932728;XM_932737;XM_940636;XM_944691;XM_944696;XM_944702 |
OSR2 | odd-skipped related 2 (Drosophila) | NM_053001 |
FLJ21986 | hypothetical protein FLJ21986 | NM_024913 |
IRAK1BP1 | interleukin-1 receptor-associated kinase 1 binding protein 1 | NM_001010844 |
IGFBP7 | insulin-like growth factor binding protein 7 | NM_001553 |
BNIP3 | BCL2/adenovirus E1B 19kDa interacting protein 3 | NM_004052 |
PELI2 | pellino homolog 2 (Drosophila) | NM_021255 |
AGTPBP1 | ATP/GTP binding protein 1 | NM_015239 |
RBMS3 | RNA binding motif, single stranded interacting protein | NM_001003792;NM_001003793;NM_014483 |
COL14A1 | collagen, type XIV, alpha 1 (undulin) | NM_021110 |
CFH | complement factor H | NM_000186;NM_001014975 |
PTGIS | prostaglandin I2 (prostacyclin) synthase | NM_000961 |
SNED1 | sushi, nidogen and EGF-like domains 1 | XM_059482;XM_940984 |
CDH12 | cadherin 12, type 2 (N-cadherin 2) | NM_004061 |
PHIP | pleckstrin homology domain interacting protein | NM_017934 |
PNN | pinin, desmosome associated protein | NM_002687 |
NDUFS4 | NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase) | NM_002495 |
ZNF521 | zinc finger protein 521 | NM_015461 |
VNN1 | vanin 1 | NM_004666 |
TRPS1 | trichorhinophalangeal syndrome I | NM_014112 |
ABCA8 | ATP-binding cassette, sub-family A (ABC1), member 8 | NM_007168 |
MRPS22 | mitochondrial ribosomal protein S22 | NM_020191 |
BDP1 | B double prime 1, subunit of RNA polymerase III transcription initiation factor IIIB | NM_018429 |
MAMDC2 | MAM domain containing 2 | NM_153267 |
PCDH19 | protocadherin 19 | NM_020766 |
AMY1A;AMY1B;AMY1C;AMY2A;AMY2B | amylase, alpha 1A;salivary;amylase, alpha 1B;amylase, alpha 1C;amylase, alpha 2A;pancreatic;amylase, alpha 2B (pancreatic) | NM_001008221;NM_004038;NM_001008218;NM_001008219;NM_000699;NM_020978 |
PLEKHH2 | pleckstrin homology domain containing, family H (with MyTH4 domain) member 2 | NM_172069 |
DYNC2LI1 | dynein, cytoplasmic 2, light intermediate chain 1 | NM_001012665;NM_015522;NM_016008 |
MRPS22 | mitochondrial ribosomal protein S22 | NM_020191 |
FLJ46688 | FLJ46688 protein | NM_001004330 |
ELOVL4 | elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 4 | NM_022726 |
BRWD1 | bromodomain and WD repeat domain containing 1 | NM_001007246;NM_018963;NM_033656 |
MFAP5 | microfibrillar associated protein 5 | NM_003480 |
ZNF415 | zinc finger protein 415 | NM_018355 |
PZP | pregnancy-zone protein | NM_002864 |
KIAA1377 | KIAA1377 | NM_020802 |
ZNF292 | zinc finger protein 292 | XM_048070;XM_932361;XM_932366;XM_938563;XM_943726;XM_943729 |
ATXN3 | ataxin 3 | NM_001024631;NM_004993;NM_030660 |
EDG2 | endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 2 | NM_001401;NM_057159 |
STEAP1 | six transmembrane epithelial antigen of the prostate 1 | NM_012449 |
ZNF91 | zinc finger protein 91 | NM_003430 |
TTC3 | tetratricopeptide repeat domain 3 | NM_001001894;NM_003316 |
OMD | osteomodulin | NM_005014 |
ECHDC1 | enoyl Coenzyme A hydratase domain containing 1 | NM_018479 |
OGN | osteoglycin (osteoinductive factor, mimecan) | NM_014057;NM_024416;NM_033014 |
SDCCAG1 | serologically defined colon cancer antigen 1 | NM_004713 |
AGR2 | anterior gradient 2 homolog (Xenopus laevis) | NM_006408 |
PPAP2B | phosphatidic acid phosphatase type 2B | NM_003713;NM_177414 |
ZNF83 | zinc finger protein 83 | NM_018300 |
DYNC2LI1 | dynein, cytoplasmic 2, light intermediate chain 1 | NM_001012665;NM_015522;NM_016008 |
USP53 | ubiquitin specific peptidase 53 | NM_019050 |
C11orf74 | chromosome 11 open reading frame 74 | NM_138787 |
JMJD1C | jumonji domain containing 1C | NM_004241 |
PCM1 | pericentriolar material 1 | NM_006197 |
FLJ20152 | hypothetical protein FLJ20152 | NM_001034850;NM_019000 |
FBLN1 | fibulin 1 | NM_001996;NM_006485;NM_006486;NM_006487 |
CROP | cisplatin resistance-associated overexpressed protein | NM_006107;NM_016424 |
ESCO1 | establishment of cohesion 1 homolog 1 (S. cerevisiae) | NM_052911 |
GTF2F2 | general transcription factor IIF, polypeptide 2, 30kDa | NM_004128 |
DCN | decorin | NM_001920;NM_133503;NM_133504;NM_133505;NM_133506;NM_133507 |
KIF5B | kinesin family member 5B | NM_004521 |
C20orf19 | chromosome 20 open reading frame 19 | NM_018474 |
CFH;CFHR1 | complement factor H;complement factor H-related 1 | NM_000186;NM_001014975;NM_002113 |
DPT | dermatopontin | NM_001937 |
AKR1C1 | aldo-keto reductase family 1, member C1 (dihydrodiol dehydrogenase 1;20-alpha (3-alpha)-hydroxysteroid dehydrogenase) | NM_001353 |
PAPPA | pregnancy-associated plasma protein A, pappalysin 1 | NM_002581 |
KIAA0738 | KIAA0738 gene product | NM_014719 |
LDB3 | LIM domain binding 3 | NM_007078 |
RECK | reversion-inducing-cysteine-rich protein with kazal motifs | NM_021111 |
MLL5 | myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog, Drosophila) | NM_018682;NM_182931 |
PPARG | peroxisome proliferative activated receptor, gamma | NM_005037;NM_015869;NM_138711;NM_138712 |
RBMS3 | RNA binding motif, single stranded interacting protein | NM_001003792;NM_001003793;NM_014483 |
COX7C | cytochrome c oxidase subunit VIIc | NM_001867 |
AOX1 | aldehyde oxidase 1 | L11005 |
WISP2 | WNT1 inducible signaling pathway protein 2 | AK074695 |
LOX | lysyl oxidase | NM_002317 |
CFD | complement factor D (adipsin) | BQ712715 |
ICEBERG | ICEBERG caspase-1 inhibitor | DB328860 |
SCEL | sciellin | BC047536 |
DEFB1 | defensin, beta 1 | BG696638 |
SPINK5 | serine peptidase inhibitor, Kazal type 5 | DQ149928 |
Claims (10)
- WNT3(NM_030753)의 폴리뉴클레오티드 또는 그 단편으로서 10개 이상의 연속 뉴클레오티드를 포함하는 폴리뉴클레오티드,또는 그의 상보적 폴리뉴클레오티드; 및상기 폴리뉴클레오티드를 표면에 결합시킨 고상 지지체를 포함하며,진단 대상 피부세포의 전사체 중에서 상기 폴리뉴클레오티드에 혼성화된 전사체의 양이 검버섯이 발생되지 않은 대조군보다 많으면 검버섯 발생 피부로 진단하는 것을 특징으로 하는 검버섯 발생 진단 키트.
- 제 1 항에 있어서,상기 WNT3(NM_030753) 외에 추가적으로, TFIP11(NM_001008697;NM_012143), DUS3L(NM_020175), CDH3(NM_001793), PLAU(NM_002658), AQP3(NM_004925), CENPO(NM_024322), CDCP1(NM_022842;NM_178181), NEFL(NM_006158), TAX1BP3(NM_014604), COPZ2(NM_016429), SSBP3(NM_001009955;NM_018070;NM_145716), TNFRSF21(NM_014452), ZFP14(NM_020917), LOXL2(NM_002318), CCL2(NM_002982), RNASET2(NM_003730), KRTCAP3(NM_173853), SLC38A5(NM_033518), ZNRF1(NM_032268), TNC(NM_002160), SYT12(NM_177963), SYXBP5L(XM_045911;XM_938898), RBM14(NM_006328), GSR(NM_000637), ZC3HAV1(NM_020119;NM_024625), AQP3(NM_004925), MGC17330(NM_052880), PRSS16(NM_005865), MYO1F(NM_012335), SLC12A4(NM_005072), ITGA2(NM_002203), WNT5B(NM_030775;NM_032642), HNRPU(NM_004501;NM_031844), LTB4R2(NM_019839), KCNC4(NM_001039574;NM_004978;NM_153763), H2AFY2(NM_018649), BTN2A2(NM_006995;NM_181531), DYNLL2(NM_080677), ETV5(NM_004454), PCDHB13(NM_018933), ITGB4(NM_000213;NM_001005619;NM_001005731), GGA2(NM_015044), JAG2(NM_002226;NM_145159), COL17A1(NM_000494;NM_130778), DLX2(NM_004405), LDLR(NM_000527), GPRC5C(NM_018653;NM_022036), FBXO4(NM_012176;NM_033484), STC1(NM_003155), COL4A2(NM_001846), ADAMTSL3(NM_207517), KLC4(NM_138343;NM_201521;NM_201522;NM_201523), ID1(NM_002165;NM_181353), GALNT14(NM_024572), PAX6(NM_000280;NM_001604), IGFL1(BG775668), PLAT(BX641021), TNS4(AF370421), CLSTN1(AB020718), HOXA7(NM_006896), SILV(AK092881), MX1(AK096355) 및 CIDEB(AK122828)로 이루어진 군으로부터 선택된 하나 이상의 폴리뉴클레오티드 또는 그 단편으로서 10개 이상의 연속 뉴클레오티드를 더 포함하는 폴리뉴클레오티드,또는 그의 상보적 폴리뉴클레오티드; 및상기 폴리뉴클레오티드를 표면에 결합시킨 고상 지지체를 포함하며,진단 대상 피부세포의 전사체 중에서 상기 폴리뉴클레오티드에 혼성화된 전사체의 양이 검버섯이 발생되지 않은 대조군보다 많으면 검버섯 발생 피부로 진단하는 것을 특징으로 하는 검버섯 발생 진단 키트.
- WNT3(NM_030753)의 폴리뉴클레오티드의 단편으로서 18-22개의 연속 뉴클레오티드를 포함하는 폴리뉴클레오티드; 및상기 폴리뉴클레오티드에 상보적인 폴리뉴클레오티드의 단편으로서 18-22개의 연속 뉴클레오티드를 포함하는 하나 이상의 폴리뉴클레오티드를 포함하며,진단 대상 피부세포에서 상기 폴리뉴클레오티드들을 프라이머로 하여 증폭된 DNA 양이 검버섯이 발생되지 않은 대조군보다 많으면 검버섯 발생 피부로 진단하는 것을 특징으로 하는 검버섯 발생 진단 키트.
- 제 3 항에 있어서,상기 WNT3(NM_030753) 외에 추가적으로, TFIP11(NM_001008697;NM_012143), DUS3L(NM_020175), CDH3(NM_001793), PLAU(NM_002658), AQP3(NM_004925), CENPO(NM_024322), CDCP1(NM_022842;NM_178181), NEFL(NM_006158), TAX1BP3(NM_014604), COPZ2(NM_016429), SSBP3(NM_001009955;NM_018070;NM_145716), TNFRSF21(NM_014452), ZFP14(NM_020917), LOXL2(NM_002318), CCL2(NM_002982), RNASET2(NM_003730), KRTCAP3(NM_173853), SLC38A5(NM_033518), ZNRF1(NM_032268), TNC(NM_002160), SYT12(NM_177963), SYXBP5L(XM_045911;XM_938898), RBM14(NM_006328), GSR(NM_000637), ZC3HAV1(NM_020119;NM_024625), AQP3(NM_004925), MGC17330(NM_052880), PRSS16(NM_005865), MYO1F(NM_012335), SLC12A4(NM_005072), ITGA2(NM_002203), WNT5B(NM_030775;NM_032642), HNRPU(NM_004501;NM_031844), LTB4R2(NM_019839), KCNC4(NM_001039574;NM_004978;NM_153763), H2AFY2(NM_018649), BTN2A2(NM_006995;NM_181531), DYNLL2(NM_080677), ETV5(NM_004454), PCDHB13(NM_018933), ITGB4(NM_000213;NM_001005619;NM_001005731), GGA2(NM_015044), JAG2(NM_002226;NM_145159), COL17A1(NM_000494;NM_130778), DLX2(NM_004405), LDLR(NM_000527), GPRC5C(NM_018653;NM_022036), FBXO4(NM_012176;NM_033484), STC1(NM_003155), COL4A2(NM_001846), ADAMTSL3(NM_207517), KLC4(NM_138343;NM_201521;NM_201522;NM_201523), ID1(NM_002165;NM_181353), GALNT14(NM_024572), PAX6(NM_000280;NM_001604), IGFL1(BG775668), PLAT(BX641021), TNS4(AF370421), CLSTN1(AB020718), HOXA7(NM_006896), SILV(AK092881), MX1(AK096355) 및 CIDEB(AK122828)로 이루어진 군으로부터 선택된 폴리뉴클레오티드의 단편으로서 18-22개의 연속 뉴클레오티드를 더 포함하는 하나 이상의 폴리뉴클레오티드; 및상기 폴리뉴클레오티드에 상보적인 폴리뉴클레오티드의 단편으로서 18-22개의 연속 뉴클레오티드를 포함하는 하나 이상의 폴리뉴클레오티드를 포함하며,진단 대상 피부세포에서 상기 폴리뉴클레오티드들을 프라이머로 하여 증폭된 DNA 양이 검버섯이 발생되지 않은 대조군보다 많으면 검버섯 발생 피부로 진단하는 것을 특징으로 하는 검버섯 발생 진단 키트.
- WNT3(NM_030753) 유전자에 의하여 코딩되는 폴리펩티드에 대한 모노클로날 항체를 포함하며,진단 대상 피부세포에서 상기 항체에 결합된 항원의 양이 검버섯이 발생되지 않은 대조군보다 많으면 검버섯 발생 피부로 진단하는 것을 특징으로 하는 검버섯 발생 진단 키트.
- 제 5 항에 있어서,상기 WNT3(NM_030753) 외에 추가적으로, TFIP11(NM_001008697;NM_012143), DUS3L(NM_020175), CDH3(NM_001793), PLAU(NM_002658), AQP3(NM_004925), CENPO(NM_024322), CDCP1(NM_022842;NM_178181), NEFL(NM_006158), TAX1BP3(NM_014604), COPZ2(NM_016429), SSBP3(NM_001009955;NM_018070;NM_145716), TNFRSF21(NM_014452), ZFP14(NM_020917), LOXL2(NM_002318), CCL2(NM_002982), RNASET2(NM_003730), KRTCAP3(NM_173853), SLC38A5(NM_033518), ZNRF1(NM_032268), TNC(NM_002160), SYT12(NM_177963), SYXBP5L(XM_045911;XM_938898), RBM14(NM_006328), GSR(NM_000637), ZC3HAV1(NM_020119;NM_024625), AQP3(NM_004925), MGC17330(NM_052880), PRSS16(NM_005865), MYO1F(NM_012335), SLC12A4(NM_005072), ITGA2(NM_002203), WNT5B(NM_030775;NM_032642), HNRPU(NM_004501;NM_031844), LTB4R2(NM_019839), KCNC4(NM_001039574;NM_004978;NM_153763), H2AFY2(NM_018649), BTN2A2(NM_006995;NM_181531), DYNLL2(NM_080677), ETV5(NM_004454), PCDHB13(NM_018933), ITGB4(NM_000213;NM_001005619;NM_001005731), GGA2(NM_015044), JAG2(NM_002226;NM_145159), COL17A1(NM_000494;NM_130778), DLX2(NM_004405), LDLR(NM_000527), GPRC5C(NM_018653;NM_022036), FBXO4(NM_012176;NM_033484), STC1(NM_003155), COL4A2(NM_001846), ADAMTSL3(NM_207517), KLC4(NM_138343;NM_201521;NM_201522;NM_201523), ID1(NM_002165;NM_181353), GALNT14(NM_024572), PAX6(NM_000280;NM_001604), IGFL1(BG775668), PLAT(BX641021), TNS4(AF370421), CLSTN1(AB020718), HOXA7(NM_006896), SILV(AK092881), MX1(AK096355) 및 CIDEB(AK122828)로 이루어진 군으로부터 선택된 유전자에 의하여 코딩되는 폴리펩티드에 대한 모노클로날 항체를 하나 이상 더 포함하며,진단 대상 피부세포에서 상기 항체에 결합된 항원의 양이 검버섯이 발생되지 않은 대조군보다 많으면 검버섯 발생 피부로 진단하는 것을 특징으로 하는 검버섯 발생 진단 키트.
- 검버섯 발생을 진단하기 위해 필요한 정보를 제공하는 방법으로서,진단 대상 표피 중의 WNT3(NM_030753) 유전자의 발현량이 검버섯이 발생되지 않은 대조군보다 많으면 검버섯 발생 피부인 것으로 판단하는 것을 특징으로 하는 검버섯 발생을 진단하기 위해 필요한 정보를 제공하는 방법.
- 제 7 항에 있어서,검버섯 발생을 진단하기 위해 필요한 정보를 제공하는 방법으로서,진단 대상 표피 중의 상기 WNT3(NM_030753) 외에 추가적으로, TFIP11(NM_001008697;NM_012143), DUS3L(NM_020175), CDH3(NM_001793), PLAU(NM_002658), AQP3(NM_004925), CENPO(NM_024322), CDCP1(NM_022842;NM_178181), NEFL(NM_006158), TAX1BP3(NM_014604), COPZ2(NM_016429), SSBP3(NM_001009955;NM_018070;NM_145716), TNFRSF21(NM_014452), ZFP14(NM_020917), LOXL2(NM_002318), CCL2(NM_002982), RNASET2(NM_003730), KRTCAP3(NM_173853), SLC38A5(NM_033518), ZNRF1(NM_032268), TNC(NM_002160), SYT12(NM_177963), SYXBP5L(XM_045911;XM_938898), RBM14(NM_006328), GSR(NM_000637), ZC3HAV1(NM_020119;NM_024625), AQP3(NM_004925), MGC17330(NM_052880), PRSS16(NM_005865), MYO1F(NM_012335), SLC12A4(NM_005072), ITGA2(NM_002203), WNT5B(NM_030775;NM_032642), HNRPU(NM_004501;NM_031844), LTB4R2(NM_019839), KCNC4(NM_001039574;NM_004978;NM_153763), H2AFY2(NM_018649), BTN2A2(NM_006995;NM_181531), DYNLL2(NM_080677), ETV5(NM_004454), PCDHB13(NM_018933), ITGB4(NM_000213;NM_001005619;NM_001005731), GGA2(NM_015044), JAG2(NM_002226;NM_145159), COL17A1(NM_000494;NM_130778), DLX2(NM_004405), LDLR(NM_000527), GPRC5C(NM_018653;NM_022036), FBXO4(NM_012176;NM_033484), STC1(NM_003155), COL4A2(NM_001846), ADAMTSL3(NM_207517), KLC4(NM_138343;NM_201521;NM_201522;NM_201523), ID1(NM_002165;NM_181353), GALNT14(NM_024572), PAX6(NM_000280;NM_001604), IGFL1(BG775668), PLAT(BX641021), TNS4(AF370421), CLSTN1(AB020718), HOXA7(NM_006896), SILV(AK092881), MX1(AK096355) 및 CIDEB(AK122828)로 이루어진 군으로부터 선택되는 하나 이상의 유전자의 발현량이 검버섯이 발생되지 않은 대조군보다 많으면 검버섯 발생 피부인 것으로 판단하는 것을 특징으로 하는 검버섯 발생을 진단하기 위해 필요한 정보를 제공하는 방법.
- 검버섯 발생 억제제를 스크리닝하는 방법으로서,세포에 시험 물질을 처리하는 단계; 및시험 물질 처리 후 세포 내 WNT3(NM_030753) 유전자에 의하여 코딩되는 단백질의 발현이 억제되는지를 확인하는 단계를 포함하는 것을 특징으로 하는 검버섯 발생 억제제 스크리닝 방법.
- 제 9 항에 있어서,검버섯 발생 억제제를 스크리닝하는 방법으로서,세포에 시험 물질을 처리하는 단계; 및시험 물질 처리 후 세포 내, 상기 WNT3(NM_030753) 외에 추가적으로, TFIP11(NM_001008697;NM_012143), DUS3L(NM_020175), CDH3(NM_001793), PLAU(NM_002658), AQP3(NM_004925), CENPO(NM_024322), CDCP1(NM_022842;NM_178181), NEFL(NM_006158), TAX1BP3(NM_014604), COPZ2(NM_016429), SSBP3(NM_001009955;NM_018070;NM_145716), TNFRSF21(NM_014452), ZFP14(NM_020917), LOXL2(NM_002318), CCL2(NM_002982), RNASET2(NM_003730), KRTCAP3(NM_173853), SLC38A5(NM_033518), ZNRF1(NM_032268), TNC(NM_002160), SYT12(NM_177963), SYXBP5L(XM_045911;XM_938898), RBM14(NM_006328), GSR(NM_000637), ZC3HAV1(NM_020119;NM_024625), AQP3(NM_004925), MGC17330(NM_052880), PRSS16(NM_005865), MYO1F(NM_012335), SLC12A4(NM_005072), ITGA2(NM_002203), WNT5B(NM_030775;NM_032642), HNRPU(NM_004501;NM_031844), LTB4R2(NM_019839), KCNC4(NM_001039574;NM_004978;NM_153763), H2AFY2(NM_018649), BTN2A2(NM_006995;NM_181531), DYNLL2(NM_080677), ETV5(NM_004454), PCDHB13(NM_018933), ITGB4(NM_000213;NM_001005619;NM_001005731), GGA2(NM_015044), JAG2(NM_002226;NM_145159), COL17A1(NM_000494;NM_130778), DLX2(NM_004405), LDLR(NM_000527), GPRC5C(NM_018653;NM_022036), FBXO4(NM_012176;NM_033484), STC1(NM_003155), COL4A2(NM_001846), ADAMTSL3(NM_207517), KLC4(NM_138343;NM_201521;NM_201522;NM_201523), ID1(NM_002165;NM_181353), GALNT14(NM_024572), PAX6(NM_000280;NM_001604), IGFL1(BG775668), PLAT(BX641021), TNS4(AF370421), CLSTN1(AB020718), HOXA7(NM_006896), SILV(AK092881), MX1(AK096355) 및 CIDEB(AK122828)로 이루어진 군으로부터 선택되는 하나 이상의 유전자에 의하여 코딩되는 단백질의 발현이 억제되는지를 확인하는 단계를 포함하는 것을 특징으로 하는 검버섯 발생 억제제 스크리닝 방법.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070118030A KR101000608B1 (ko) | 2007-11-19 | 2007-11-19 | 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070118030A KR101000608B1 (ko) | 2007-11-19 | 2007-11-19 | 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020090132555A Division KR101252338B1 (ko) | 2009-12-29 | 2009-12-29 | 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090051573A KR20090051573A (ko) | 2009-05-22 |
KR101000608B1 true KR101000608B1 (ko) | 2010-12-10 |
Family
ID=40859625
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070118030A KR101000608B1 (ko) | 2007-11-19 | 2007-11-19 | 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101000608B1 (ko) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101886342B1 (ko) * | 2010-11-30 | 2018-08-10 | (주)아모레퍼시픽 | 피부 노화와 관련된 유전자 및 피부 노화를 방지하는 물질을 스크리닝하는 방법 |
KR101971358B1 (ko) * | 2016-09-26 | 2019-04-23 | 동국대학교 산학협력단 | 검버섯 진단용 마커로서의 구아닌 탈아미노효소의 용도 |
CN108410984B (zh) * | 2018-02-11 | 2021-08-31 | 中山大学 | Rbms3作为肿瘤耐药检测、治疗及预后分子靶点的应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020111290A1 (en) | 2000-12-01 | 2002-08-15 | Bernhard Homey | Uses of mammalian genes and related reagents |
JP2007289063A (ja) | 2006-04-25 | 2007-11-08 | Shiseido Co Ltd | しみ部位亢進遺伝子群を指標とした皮膚しみ形成予知方法、皮膚しみ形成抑制剤のスクリーニング方法 |
-
2007
- 2007-11-19 KR KR1020070118030A patent/KR101000608B1/ko active IP Right Grant
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020111290A1 (en) | 2000-12-01 | 2002-08-15 | Bernhard Homey | Uses of mammalian genes and related reagents |
JP2007289063A (ja) | 2006-04-25 | 2007-11-08 | Shiseido Co Ltd | しみ部位亢進遺伝子群を指標とした皮膚しみ形成予知方法、皮膚しみ形成抑制剤のスクリーニング方法 |
Also Published As
Publication number | Publication date |
---|---|
KR20090051573A (ko) | 2009-05-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11519036B2 (en) | Use of microvesicles in analyzing nucleic acid profiles | |
EP2867376B1 (en) | Targeted rna-seq methods and materials for the diagnosis of prostate cancer | |
FR2892730A1 (fr) | Methode pour detecter la presence ou le risque de developper un cancer | |
US20130040833A1 (en) | Use of microvesicles in analyzing nucleic acid profiles | |
Stemmler et al. | Trying to understand the genetics of atopic dermatitis | |
KR101000608B1 (ko) | 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 | |
EP4176084A1 (fr) | Procédé pour déterminer le risque de survenue d'une infection associée aux soins chez un patient | |
KR101252338B1 (ko) | 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 | |
KR101231993B1 (ko) | 검버섯 발생 진단 키트 및 검버섯 발생 진단 방법 | |
JP2007143504A (ja) | 高血圧の遺伝子マーカー | |
US7919240B2 (en) | Altered gene expression profiles in stable versus acute childhood asthma | |
KR100947738B1 (ko) | 피부 노화 진단 키트 및 피부 노화 진단 방법 | |
Popp et al. | Development of a microarray chip for gene expression in rabbit ocular research | |
WO2022008827A1 (fr) | Procédé pour déterminer le risque de survenue d'une infection associée aux soins chez un patient | |
EP4176086A1 (fr) | Procédé pour déterminer le risque de survenue d'une infection associée aux soins chez un patient | |
KR101231297B1 (ko) | 피부 노화 진단 키트 및 피부 노화 진단 방법 | |
US20130040846A1 (en) | Signatures for Kidney Aging | |
KR101316998B1 (ko) | 피부 노화 진단 키트 및 피부 노화 진단 방법 | |
RU2445625C1 (ru) | Способ прогнозирования риска развития многоузловых поражений при лейомиоме матки | |
CN116144759A (zh) | LncRNA-ENST00000581911在制备甲状腺相关眼病诊断试剂中的应用 | |
KR101543177B1 (ko) | 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 | |
KR100706032B1 (ko) | 파클리탁셀 방출스텐트의 시술을 위한 유전자형 분석키트 | |
KR101543183B1 (ko) | 민감성 피부 진단용 바이오 마커 및 이를 이용한 진단 키트 | |
EP4034679A1 (fr) | Procédé pour déterminer le risque de survenue d'une infection associée aux soins chez un patient | |
WO2022008826A1 (fr) | Procédé pour déterminer le risque de complication chez un patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
A107 | Divisional application of patent | ||
E90F | Notification of reason for final refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20131121 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20141120 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20151130 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20161010 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20170928 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20181002 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20190926 Year of fee payment: 10 |